CA2562313C — Systems and methods for administering a medical regimen
Assigned to Becton Dickinson and Co · Expires 2012-10-16 · 14y expired
What this patent protects
A medical regimen can be administered with a diagnostic and medication delivery system. In one form the system includes a medication delivery pen with a controller and a monitor for monitoring a characteristic of a bodily fluid with a controller. A case includes a compartment for…
USPTO Abstract
A medical regimen can be administered with a diagnostic and medication delivery system. In one form the system includes a medication delivery pen with a controller and a monitor for monitoring a characteristic of a bodily fluid with a controller. A case includes a compartment for removably storing the medication delivery pen and the monitor. The case includes a communications link for establishing communication between the controller of the pen and the controller of the monitor. The medication delivery pen and monitor are operable in a first mode cooperative with one another and in a second mode independent of one another.
Drugs covered by this patent
- naloxone-hydrochloride (Naloxone Hydrochloride) · Pfizer Inc.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.